Data gathered: December 6
Data Bits
Data Bits | Value / Change | Benchmark | |
---|---|---|---|
Job Posts | 8 0% |
|
|
Sentiment | 79 5.3% |
|
|
Webpage traffic | 17,000 6% |
|
|
Employee Rating | 76 0% |
|
|
Google Trends | 0% |
|
|
Linkedin Employees | 418 N/A |
|
|
Patents | 30 0% |
|
|
4chan Mentions | 0% | N/A | |
Facebook Engagement | 1 0% |
|
|
Facebook followers | 876 0% |
|
|
Stocktwits Mentions | 6 -25% |
|
|
Stocktwits Subscribers | 7,941 -0.1% |
|
|
Twitter Followers | 1,524 0% |
|
|
News Mentions | 0% |
|
|
Reddit Mentions | 0% |
|
|
Business outlook | 64 0% |
|
In the news
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)December 3 - Finnhub |
|
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)December 1 - Yahoo |
|
![]() |
Karyopharm Therapeutics: Promising Potential With 3 Ongoing Phase 3 Studies But RiskyNovember 29 - SeekingAlpha |
Karyopharm Therapeutics; Promising Potential With 3 Ongoing Phase 3 Studies But RiskyNovember 28 - Seeking Alpha |
|
Karyopharm to Participate at Upcoming Investor ConferencesNovember 8 - Yahoo |
|
Karyopharm Announces New Preliminary Data in Overall Survival (OS) in Selinexor-Treated Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer as Part of Pre-Specified Exploratory Subgroup Analysis of the SIENDO StudyNovember 5 - Yahoo |
About Karyopharm Therapeutics
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases.

Price | $0.84 |
Target Price | Sign up |
Market Cap | $100M |
Dividend Yield | 0 |
Industry | Biotechnology |
Similar companies
Financial performance View All
Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
---|---|---|---|---|---|
Q3 '23 | 30M | 31M | -870,000 | -35M | -28M |
Q2 '23 | 32M | 34M | -2.7M | -33M | -27M |
Q1 '23 | 33M | 36M | -3M | -34M | -28M |
Q4 '22 | 28M | 35M | -7M | -39M | -33M |
Q3 '22 | 30M | 35M | -4.6M | -36M | -30M |
Insider Transactions
Paulson Richard A. filed to sell 787,579 shares at $0.8. December 5 '23 |
Paulson Richard A. filed to sell 791,201 shares at $0.9. November 7 '23 |
Paulson Richard A. filed to sell 794,807 shares at $1.3. October 5 '23 |
Paulson Richard A. filed to sell 798,396 shares at $1.3. September 6 '23 |
Cheng Sohanya Roshan filed to sell 204,086 shares at $1.3. September 5 '23 |